Nephrogen
Curative gene therapies for kidney diseases
New York, United States · Founded 2022
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Website
- nephrogenbiotech.com
About
Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.
Summary
Nephrogen is a Biotech company based in New York, United States, founded in 2022.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...